Roulston J E, Wathen C G
Clin Chim Acta. 1984 Mar 27;138(1):99-103. doi: 10.1016/0009-8981(84)90357-7.
Samples of plasma from ten normotensive volunteers and ten hypertensive patients were assayed for plasma renin activity before and after the addition of either captopril or captopril and angiotensin II. The study was repeated after treating portions of the same specimens with trypsin, to activate the inactive renin component. The results indicate that inactive renin is not converted to the active form by captopril in vitro, nor does the addition of angiotensin II inactivate the active form. These data are consistent with the in vivo findings that changes in active and inactive renin occur independently under conditions of challenge by captopril or angiotensin II analogues.
对十名血压正常志愿者和十名高血压患者的血浆样本,在添加卡托普利或卡托普利与血管紧张素II之前和之后测定血浆肾素活性。在用胰蛋白酶处理相同标本的部分以激活无活性肾素成分后,重复该研究。结果表明,体外卡托普利不会将无活性肾素转化为活性形式,添加血管紧张素II也不会使活性形式失活。这些数据与体内研究结果一致,即在卡托普利或血管紧张素II类似物激发条件下,活性肾素和无活性肾素的变化是独立发生的。